FDA Calls for Stronger Warnings on 4 Crohn's Disease Drugs

Laura Editor
  • Today the FDA called for stronger warning labels on four of the largest selling Crohn's disease drugs: Remicade, Humira, Enbrel, and Cimzia.


    The call for stricter warning labels are a result of the increased risk of serious fungal infections associated with the drugs. Specifically, the FDA reported 240 cases of histoplasmosis in patients taking the drugs. Histoplasmosis is a respiratory disease with flu like symptoms. If untreated the disease is deadly.


    For the full story, read the Wall Street Journal's article here.




    Add This Infographic to Your Website or Blog With This Code:
Published On: September 04, 2008